Barrow, Hanley, Mewhinney & Strauss
ARA

Barrow, Hanley, Mewhinney & Strauss’s American Renal Associates Holdings, Inc ARA Stock Holding History

Barrow, Hanley, Mewhinney & Strauss’s Portfolio ARA Stock Details ARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-7,084
Closed -$48K – 350
2020
Q3 		$48K Buy
+7,084
New +$46.5K ﹤0.01% 300

Other funds holding ARA

CP
Centerbridge Partners New York $38.1M AUM 9.24% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss's ARA Position: Q4 2020 in Review

Barrow, Hanley, Mewhinney & Strauss sold out of American Renal Associates Holdings, Inc (ARA) in Q4 2020, closing a stake of 7,084 shares — an estimated $48K sold.

Barrow, Hanley, Mewhinney & Strauss first reported a position in ARA in Q3 2020 and held it in 1 quarter. The position peaked at $48K in Q3 2020. 67 funds tracked by Wall St. Rank hold ARA as of Q4 2020.

  • Barrow, Hanley, Mewhinney & Strauss reported no remaining American Renal Associates Holdings, Inc position as of Q4 2020 after selling out during the quarter.
  • Barrow, Hanley, Mewhinney & Strauss sold 7,084 American Renal Associates Holdings, Inc shares in Q4 2020, an estimated $48K.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in American Renal Associates Holdings, Inc in Q3 2020 and held it in 1 quarter.
  • Barrow, Hanley, Mewhinney & Strauss's American Renal Associates Holdings, Inc position peaked at $48K in Q3 2020.
  • 67 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q4 2020.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q4 2020, filed 11 Feb 2021.